Inicio › Cáncer de riñón (carcinoma de células renales) › Nueva York

Ensayos clínicos de Cáncer de riñón (carcinoma de células renales) en Nueva York

36 estudios sobre Cáncer de riñón (carcinoma de células renales) buscan participantes en Nueva York.

Ciudades en Nueva York

Texto oficial del estudio (inglés)

A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors

Research Site, New York
Research Site, New York

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 5 oct 2026 · NCT05536141

Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma

NEO-811 Long Island Site, Lake Success
NEO-811 NYC Site, New York

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 5 oct 2026 · NCT07300241

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

START New York Long Island LLC, Lake Success

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 2 oct 2026 · NCT06270706

A Phase 1 Study of the Safety and Tolerability of CTX-10726

START New York, Lake Success

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 2 oct 2026 · NCT07419841

Substudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy (MK-3475-03C/KEYMAKER-U03)

Perlmutter Cancer Center at NYU Langone Hospital - Long Island ( Site 5026), Mineola
Laura and Isaac Perlmutter Cancer Center ( Site 5016), New York
Memorial Sloan Kettering Cancer Center ( Site 5002), New York

ReclutandoFase 1/2

Edades de 18 a 120 · Todos los sexos · Actualizado el 2 oct 2026 · NCT07049926

A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma

Memorial Sloan Kettering Cancer Center, New York

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 2 oct 2026 · NCT06234605

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Queens Hospital Center, Jamaica
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
Stony Brook University Medical Center, Stony Brook

ReclutandoEstudio observacionalSe aceptan voluntarios sanos

Edades de 40 a 75 · Todos los sexos · Actualizado el 2 oct 2026 · NCT05334069

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Exelixis Clinical Site #60, New York
Exelixis Clinical Site #6, New York
Exelixis Clinical Site #76, Syracuse

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 1 oct 2026 · NCT05176483

Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma

Roswell Park Comprehensive, Buffalo

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 1 oct 2026 · NCT05287945

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Memorial Sloan Kettering Commack, Commack
Memorial Sloan Kettering Westchester, Harrison
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
y 3 más

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 30 sept 2026 · NCT03866382

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

NYU Langone Medical Center, New York

ReclutandoEstudio observacional

Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT04981119

A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034)

Memorial Sloan Kettering Cancer Center ( Site 0126), New York

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT07489495

A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)

Memorial Sloan Kettering Cancer Center, New York

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 23 sept 2026 · NCT07293351

Trial of Zanzalintinib (XL092) in Combination With Immunotherapy in Patients Who Progress on Adjuvant Therapy in Clear Cell RCC

Columbia University Irving Medical Center, New York

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT06863311

Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial

Northwell Health Imbert Cancer Center, Bay Shore
Memorial Sloan Kettering Commack, Commack
Glens Falls Hospital, Glens Falls
y 10 más

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 18 sept 2026 · NCT05327686

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

New York Oncology Hematology, P.C., Albany
New York Oncology Hematology - Clifton Park Cancer Center, Clifton Park
MSK Commack, Commack
y 7 más

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 17 sept 2026 · NCT07227415

A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

Memorial Sloan Kettering Cancer Center, New York

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 15 sept 2026 · NCT07195916

GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors

Tisch Cancer Institute (TCI), Icahn School of Medicine, New York
Columbia University, New York

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 14 sept 2026 · NCT04977453

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

Roswell Park Cancer Institute, Buffalo
Hematology Oncology Associates of CNY at Camillus, Camillus
Memorial Sloan Kettering Commack, Commack
y 13 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 2 sept 2026 · NCT06661720

A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue

Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities), Commack
Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
y 1 más

Reclutando

Edades de 18 en adelante · Todos los sexos · Actualizado el 2 sept 2026 · NCT05837767

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

New York Cancer & Blood Specialists, New York
University of Rochester - Wilmot Cancer Institute, Rochester

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 27 ago 2026 · NCT06582017

Comparing Two Weight Loss Programs for the Prevention of Kidney Cancer Progression Among Patients With Small Renal Masses on Active Surveillance

Roswell Park Comprehensive Cancer Center, Buffalo

Reclutando

Edades de 18 en adelante · Todos los sexos · Actualizado el 20 ago 2026 · NCT07714018

A Study of MGC026 in Participants With Advanced Solid Tumors

START-New York Long Island, Lake Success

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 11 ago 2026 · NCT06242470

A First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)

Memorial Sloan Kettering Cancer Center, New York

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 11 ago 2026 · NCT07195682

Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

Xencor Investigative Site, New York
Xencor Investigative Site, New York

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 3 ago 2026 · NCT05433142

A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors

NYU Langone Health Perlmutter Cancer Center, New York
Icahn School of Medicine at Mount Sinai, New York
Columbia University - The Trustees of Columbia University in the City of New York, New York
y 2 más

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 9 jul 2026 · NCT03972657

A Study of Abemaciclib and Cabozantinib in People With Clear Cell Renal Cell Carcinoma (ccRCC)

Memorial Sloan Kettering Cancer Center Suffolk - Commack (Limited Protocol Activities), Commack
Memorial Sloan Kettering West Harrison (Limited Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
y 1 más

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 24 jun 2026 · NCT06835972

Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors

NYU Laura and Isaac Perlmutter Cancer Center - 34th Street /ID# 257869, New York

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 4 jun 2026 · NCT04777994

A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body

Northwell Health, Lake Success

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 28 abr 2026 · NCT06413680

Study to Evaluate the Safety and Efficacy of Bicalutamide in Combination With Sunitinib in Patients With TKIs-resistant RCC

UB/ Great Lakes Cancer Care, Buffalo

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 1 abr 2026 · NCT06222593

A Study of Cemiplimab and Fianlimab in People With Clear Cell Renal Cell Carcinoma

Memorial Sloan Kettering Cancer Center Suffolk - Commack (Limited Protocol Activities), Commack
Memorial Sloan Kettering West Harrison (Limited Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
y 1 más

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 4 mar 2026 · NCT06699602

Decision Aid (DA) for Renal Patients

NYU Langone Health, New York

Reclutando

Edades de 18 en adelante · Todos los sexos · Actualizado el 2 dic 2025 · NCT05387863

A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression

NYU Langone Health, New York

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 9 sept 2025 · NCT06682793

Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial

Roswell Park Cancer Institute, Buffalo
Northwell Health/Center for Advanced Medicine, Lake Success
University of Rochester, Rochester
y 1 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 9 sept 2025 · NCT04510597

A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)

Memorial Sloan-Kettering Cancer Center, New York

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 25 nov 2024 · NCT05824975

Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067

Roswell Park Cancer Institute, Buffalo

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 15 nov 2024 · NCT04787042

De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.